Preparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticles

References

• SnowRWGuerraCANoorAMMyintHYHaySIThe global distribution of clinical episodes of Plasmodium falciparum malariaNature200543421421715759000
   PubMed Web of Science ®Google Scholar
• BlolandPBDrug resistance in malaria Available from: http://www.who.int/csr/resources/publications/drugresist/malaria.pdfAccessed July 16, 2014
   Google Scholar
• World Health OrganizationGlobal Plan for Artemisinin Resistance ContainmentGenevaWorld Health Organization2011 Available from: http://www.who.int/malaria/publications/atoz/artemisinin_resistance_containment_2011.pdfAccessed April 13, 2014
   Google Scholar
• BairdJKHoffmanSLPrimaquine therapy for malariaClin Infect Dis2004391336134515494911
   PubMed Web of Science ®Google Scholar
• FernandoSDRodrigoCRajapakseSChemoprophylaxis in malaria: drugs, evidence of efficacy and costsAsian Pac J Trop Med20114433033621771482
   PubMed Web of Science ®Google Scholar
• HillDRBairdJKPariseMELewisLSRyanETMagillAJPrimaquine: report from CDC expert meeting on malaria chemoprophylaxis IAm J Trop Med Hyg20067540241516968913
   PubMed Web of Science ®Google Scholar
• FernandoDRodrigoCRajapakseSPrimaquine in vivax malaria: an update and review on management issuesMalar J20111035122152065
   PubMed Web of Science ®Google Scholar
• KilawaWNtoumiFMalaria, a search agenda for the eradication eraLancet20093741480148219880004
   PubMed Web of Science ®Google Scholar
• BairdJKRieckmannKHCan primaquine therapy for vivax malaria be improved?Trends Parasitol20031911512012643993
   PubMed Web of Science ®Google Scholar
• AlvingAAnoldJHockwaldRPrevention of curative action of primaquine in vivax malaria by quinine and chloroquineJ Lab Clin Med19854301306
   Google Scholar
• SinghKKVingkarSKFormulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquineInt J Pharm200834713614317709216
   PubMed Web of Science ®Google Scholar
• AllenTCullisPDrug delivery systems: entering the mainstreamScience20043031818182215031496
   PubMed Web of Science ®Google Scholar
• PetersWRobinsonBToveyGRossierJJeffordCThe chemotherapy of rodent malaria. L. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine resistant parasites. Part 3: Observations on ‘Fenzan-50F’, a difluorinated 3,3 spirocyclopentane 1,2,4- trioxaneAnn Trop Med Parasitol1993871111238561518
   PubMed Web of Science ®Google Scholar
• MalamYLoizidouMSeifalianALiposomes and nanoparticles: nanosized vehicles for drug delivery in cancerTrends Pharmacol Sci2009301159259919837467
   PubMed Web of Science ®Google Scholar
• VauthierCCouvreurPNanomedicines: a new approach for the treatment of serious diseasesJ Biomed Nanotechnol20073223234
   Web of Science ®Google Scholar
• BarrattGColloidal drug carriers: achievements and perspectivesCell Mol Life Sci200360213712613656
   PubMed Web of Science ®Google Scholar
• DevalapallyHChakilamAAmijiMMRole of nanotechnology in pharmaceutical product developmentJ Pharm Sci2007962547256517688284
   PubMed Web of Science ®Google Scholar
• SemeteBBooysenLLemmerYIn vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systemsNanomedicine20106566267120230912
   PubMed Web of Science ®Google Scholar
• SemeteBBooysenLIJKalomboLIn vivo uptake and acute immune response to orally administered chitosan and PEG coated PLGA nanoparticlesToxicol Appl Pharmacol2010249215816520851137
   PubMed Web of Science ®Google Scholar
• Bruce-ChwattLEssential MalariologyNew YorkJohn Wiley and Sons19804659
   Google Scholar
• PovinelliLMonsonTAFoxBCPariseMEMorriseyJMVaidyaABPlasmodium vivax malaria in spite of atovaquone/proguanil (malarone) prophylaxisJ Travel Med20031035335514642204
   PubMed Web of Science ®Google Scholar
• PirsonPSteigerRTrouetAThe disposition of free and liposomally encapsulated antimalarial primaquine in miceBiochem Pharmacol198231350135077150371
   PubMed Web of Science ®Google Scholar
• AricaBOzerAYErcanMTHincalAACharacterization, in vitro and in vivo studies on primaquine diphosphate liposomesJ Microencapsul1995124694858544091
   PubMed Web of Science ®Google Scholar
• EkambaramPAbdulHSPriyankaKSolid lipid nanoparticles: a reviewSci Rev Chem Commun20122180102
   Google Scholar
• ShahCShahVUpadhyayUSolid lipid nanoparticles: a reviewCurr Pharm Res201114351368
   Google Scholar
• MehnertWMäderKSolid lipid nanoparticles: production, characterization and applicationsAdv Drug Deliv Rev20014716519611311991
   PubMed Web of Science ®Google Scholar
• SjostromBBergenstahlBPreparation of submicron particles in lecithin-stabilized o/w emulsions. I. Model drug studies of the precipitation of cholesteryl acetateInt J Pharm1992885362
   Web of Science ®Google Scholar
• SiekmannBWestesenKInvestigations on solid lipid nanoparticles prepared by precipitation in o/w emulsionsEur J Pharm Biopharm199643104109
   Google Scholar
• MühlenAMehnertWDrug release and release mechanism of prednisolone loaded solid lipid nanoparticlesPharmazie199853552555
   Web of Science ®Google Scholar
• PetersWPortusJHRobinsonBLThe chemotherapy of rodent malaria XXII. The value of drug resistant strains of Plasmodium berghei in screening for schizontocidal activityAnn Trop Med Parasitol1975691551711098584
   PubMed Web of Science ®Google Scholar
• TonaLMesiaKNgimbiNPIn-vivo antimalarial activity of Cassia occidentalis, Morinda morindoides and Phyllanthus niruriAnn Trop Med Parasitol200195475711235553
   PubMed Web of Science ®Google Scholar
• WestesenKBunjesHKochMHJPhysicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potentialJ Control Release199748223236
   Web of Science ®Google Scholar
• IscanYYHekimogluSKasSHincalAAFormulation and characterization of solid lipid nanoparticles for skin delivery, conference ‘lipid and surfactant dispersed systems’MoscowProceedings Book1999163166
   Google Scholar
• SchwarzCFreitasCMehnertWMüllerRHSterilisation and physical stability of drug-free and etomidate-loaded solid lipid nanoparticlesProc Int Symp Control Release Bioact Mater199522766767
   Google Scholar
• SchwarzCFeste Lipidnanopartikel: Herstellung, Charakterisierung, Arzneistof nkorporation under freisetzung, Sterilisation und Lyophilisation [doctoral thesis]BerlinFree University of Berlin1995
   Google Scholar
• PenklerLMüllerRHRungeSARavelliVInventorsPharmatec International S.R.L., assigneePharmaceutical cyclosporin formulation with improved biopharmaceutical properties, improved physical quality and greater stability, and method for producing said formulation United States patent US6551619 B12003422
   Google Scholar
• MüllerRHMäderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEur J Pharm Biopharm200050116117710840199
   PubMed Web of Science ®Google Scholar
• SouzaLGSilvaEJMartinsALLDevelopment of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged releaseEur J Pharm Biopharm20117918919621352915
   PubMed Web of Science ®Google Scholar
• MahatoRIPharmaceutical Dosage Forms and Drug DeliveryBoca RatonCRC Press2007
   Google Scholar
• IzumikawaSYoshiokaSAsoYTakedaYPreparation of poly(l-lactide) microspheres of different crystalline morphology and effect of crystalline morphology on drug release rateJ Control Release1991152133140
   Web of Science ®Google Scholar
• GuptaNRajeraRNagpalMAroraSPrimaquine loaded chitosan nanoparticles for liver targetingPharm Nanotechnol201313543
   Google Scholar
• DudhaniARKosarajuSLBioadhesive chitosan nanoparticles: preparation and characterizationCarbohydr Polym201081243251
   Web of Science ®Google Scholar
• LiPWangYPengZDevelopment of chitosan nanoparticles as drug delivery systems for 5-fluorouracil and leucovorin blendsCarbohydr Polym201185698704
   Web of Science ®Google Scholar
• MehnertWZur MühlenADinglerAWeyhersHMüllerRHSolid lipid nanoparticles – ein neuartiger Wirkstoff-Carrier für Kosmetika und Pharmazeutika. II. Mitteilung: Wirkstoff Inkorporation, Freisetzung und SterilisierbarkeitPharm Ind199759511514
   Google Scholar